Biorecognition of antibodiesin vivo:potential in drug targeting
- 1 October 1996
- journal article
- review article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 9 (5-6) , 309-315
- https://doi.org/10.1002/(sici)1099-1352(199634/12)9:5/6<309::aid-jmr275>3.0.co;2-#
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Immunotoxins as cancer chemotherapeutic agentsDrug Development Research, 1995
- Recent developments in immunotoxin therapyCurrent Opinion in Immunology, 1994
- Metabolism of receptor targeted 111In-DTPA-glycoproteins: Identification of 111In-DTPA-ϵ-lysine as the primary metabolic and excretory productNuclear Medicine and Biology, 1994
- Imaging lung cancer with radiolabeled antibodiesSeminars in Nuclear Medicine, 1993
- Biologic properties of a Ch2 domain‐deleted recombinant immunoglobulinInternational Journal of Cancer, 1993
- Radioimmunotherapy: Clinical results and dosimetric considerationsInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- Activation of prodrugs by targeted enzymesEuropean Journal of Cancer and Clinical Oncology, 1991
- Radiolabeled Antibody Imaging in the Management of Colorectal Cancer Results of a Multicenter Clinical StudyAnnals of Surgery, 1991
- Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987